Mümin Alper Erdoğan

35PUBLICATIONS
50CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsAutoimmunityHaematological tumoursImmunogenetics (incl. genetic immunology)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Aug 27, 2026
Correction: Tber et al. Pyrido[2',1':2,3]imidazo[4,5-c]isoquinolin-5-amines as Potential Cytotoxic Agents Against Human Neuroblastoma. Pharmaceuticals 2021, 14, 750.

|Apr 06, 2026
Synthesis, Bioactivity and Molecular Modeling Studies on Benzimidazole Derivatives and Its Isosteres as Potent AChE/BChE and GSK3β Inhibitors for Alzheimer's Disease.

Gözde Sayar, Sulunay Parlar, Ayse Hande Tarikogullari

|Mar 24, 2026
Tamoxifen as a Therapeutic Intervention for Neurobehavioral Deficits in a Propionic Acid-Induced Autism Model via Anti-inflammatory Mechanisms.

Mümin Alper Erdoğan, Ahmet Koyu, Eser Öz Oyar

|Jan 12, 2026
Mitigative effects of Otilonium Bromide on methotrexate-induced hepatic damage in rats.

Murat Arı, Mumin Alper Erdogan, Oytun Erbaş

|Jan 03, 2026
Prenatal Interferon-Alpha Exposure Induces Autism-Like Neurobehavioral and Neurochemical Alterations in Male Offspring.

Güliz Otkıran, Mümin Alper Erdoğan, Yiğit Uyanıkgil

|Dec 15, 2025
Intranasal ketamine mitigates radiation-induced brain injury in a rabbit model by modulating ECM/PNN markers and neuroinflammation, with in vivo 1H-MR spectroscopy readouts.

Oytun Erbas, Mumin Alper Erdogan, Bahattin Ozkul

Pageof 6

Frequent Collaborators

9 joint publications

Oytun Erbaş

8 joint publications

Yiğit Uyanıkgil

5 joint publications

Oytun Erbaş

3 joint publications

Gürkan Yiğittürk